Taku Toyoshima Selected Research

Taku Toyoshima Research Topics

8	Thrombosis (Thrombus) 01/2023 - 05/2021
6	Chronic Limb-Threatening Ischemia 11/2023 - 09/2022
4	Atrial Fibrillation 01/2023 - 01/2022
3	Diabetes Mellitus 11/2023 - 07/2023
2	Infections 06/2024 - 01/2023
2	Pathologic Constriction (Stenosis) 06/2024 - 07/2021
2	Wounds and Injuries (Trauma) 08/2023 - 01/2023
2	Heart Failure 06/2023 - 01/2023
2	Ischemia 01/2023 - 03/2021
2	Neointima 01/2023 - 01/2023
2	Acute Coronary Syndrome 01/2022 - 11/2021
1	Embolism (Embolus) 08/2023
1	Hemorrhage 04/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Cardiomyopathies (Cardiomyopathy) 01/2023
1	Atrial Remodeling 01/2023
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2022
1	Peripheral Arterial Disease 09/2022
1	Rupture 07/2022
1	Myocardial Infarction 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Tachycardia (Tachyarrhythmias) 01/2022
1	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2022
1	Death (Near-Death Experience) 01/2022
1	Aneurysm (Aneurysms) 07/2021
1	Atherosclerotic Plaque (Atheroma) 07/2021
1	Intermittent Claudication 07/2021
1	Ulcer 03/2021

1	Fluorocarbon PolymersIBA 06/2024
1	CholesterolIBA 08/2023
1	Atrial Natriuretic Factor (ANF)IBA 01/2023
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2023
1	nitinolIBA 07/2022
1	oxidized low density lipoproteinIBA 01/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	AnticoagulantsIBA 01/2022
1	LipidsIBA 01/2022

13	Stents 06/2024 - 03/2021
6	Renal Dialysis (Hemodialysis) 11/2023 - 09/2022
6	Therapeutics 10/2023 - 03/2021
5	Drug-Eluting Stents 06/2024 - 07/2021
3	Catheter Ablation 01/2023 - 01/2022
1	Surgical Amputation (Amputations) 04/2023